Charles Bonnet syndrome precipitated by brimonidine tartrate eye drops.
نویسندگان
چکیده
منابع مشابه
[Charles Bonnet syndrome precipitated by brimonidine].
CASE REPORT An 81-year-old woman with age-related macular degeneration and pseudoexfoliative glaucoma developed visual hallucinations (faces, flowers and frames) shortly after beginning brimonidine drops. Neurologic and psychiatric examination was normal. Visual hallucinations disappeared within 10 days after discontinuing the drug. DISCUSSION The Charles Bonnet syndrome (CBS) is characterise...
متن کاملNeuroprotective effects of brimonidine treatment in a rodent model of ischemic optic neuropathy.
Ischemic optic neuropathy (ION) is a common disorder caused by disruption of the arterial blood supply to the optic nerve. It can result in significant loss of visual acuity and/or visual field. An ischemic optic nerve injury was produced in rats by intravenous injection of Rose Bengal dye followed by argon green laser application to the retinal arteries overlying the optic nerve, causing a coa...
متن کاملCOMBIGAN Eye Drops NAME OF THE DRUG
Brimonidine tartrate is an alpha-2 selective adrenergic receptor agonist for ophthalmic use. Brimonidine tartrate is a white to off-white, pale yellow powder and is water soluble (34 mg/mL). In solution, brimonidine tartrate has a clear, greenish-yellow colour. Chemical name: 5-bromo-6-(2-imidazolidinylideneamino) quinoxaline L-tartrate Molecular weight: 442.24 as the tartrate salt Empirical fo...
متن کاملFluorimetric Quantification of Brimonidine Tartrate in Eye Drops
A simple and sensitive spectrofluorimetric method has been developed for the estimation of brimonidine tartrate in pure and eye drops. Linearity was obeyed in the range of 0.2-3.0 ΅g/ml in dimethyl formamide as solvent at an emission wavelength (λem) of 530 nm after excitation wavelength (λex) of 389 nm with good correlation coefficient of 0.998. The limit of detection and limit of quantificati...
متن کاملSensitization to and allergic contact dermatitis caused by Mirvaso(®) (brimonidine tartrate) for treatment of rosacea - 2 cases.
Rosacea is characterized by transient or persistent erythema, telangiectasia, papules and pustules primarily affecting the central facial region. Recently brimonidine tartrate gel 0.33%has been approved for the topical treatment of persistent facial erythema of rosacea (1). Allergic blepharitis caused by brimonidine in patients treated with brimonidine tartrate 0.33% eye drops has been document...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The British journal of ophthalmology
دوره 87 7 شماره
صفحات -
تاریخ انتشار 2003